CHemotherapy and Stool Transplant in PDAC (CHASe-PDAC)

Clinical trial NCT06393400 · RECRUITING

Trial details

NCT number: NCT06393400
Sponsor: John Lenehan
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Unresectable or Metastatic Advanced Pancreatic Ductal Adenocarcinoma

Start date: 2025-01-08
Primary completion: 2028-02-01
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.